Tamoxifen-independent Cre-activity in SMMHC-CreER(T2) mice

BACKGROUND AND AIMS: Recent technological advances have established vascular smooth muscle cells (SMCs) as central players in atherosclerosis. Increasingly complex genetic mouse models have unveiled that 30–70% of cells in experimentally induced atherosclerotic lesions derive from a handful of media...

Descripción completa

Detalles Bibliográficos
Autores principales: Steffensen, L.B., Stubbe, J., Overgaard, M., Larsen, J.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833216/
https://www.ncbi.nlm.nih.gov/pubmed/36644559
http://dx.doi.org/10.1016/j.athplu.2022.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833216/
https://www.ncbi.nlm.nih.gov/pubmed/36644559
http://dx.doi.org/10.1016/j.athplu.2022.01.002

Ejemplares similares